The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Nora D. Volkow

Medical Department

Brookhaven National Laboratory

Upton

New York 11973

USA

[email]@bnl.gov

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Medical Department, Brookhaven National Laboratory, Upton, New York 11973, USA. 1997 - 2005
  • Department of Psychiatry, State University of New York at Stony Brook, USA. 2001
  • Medical Department, Upton, NY 11973, USA. 2000

References

  1. The slow and long-lasting blockade of dopamine transporters in human brain induced by the new antidepressant drug radafaxine predict poor reinforcing effects. Volkow, N.D., Wang, G.J., Fowler, J.S., Learned-Coughlin, S., Yang, J., Logan, J., Schlyer, D., Gatley, J.S., Wong, C., Zhu, W., Pappas, N., Schueller, M., Jayne, M., Carter, P., Warner, D., Ding, Y.S., Shea, C., Xu, Y. Biol. Psychiatry (2005) [Pubmed]
  2. Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma. Volkow, N.D., Wang, G.J., Fowler, J.S., Molina, P.E., Logan, J., Gatley, S.J., Gifford, A., Ding, Y.S., Wong, C., Pappas, N.R., Zhu, W., Swanson, J.M. Psychopharmacology (Berl.) (2003) [Pubmed]
  3. Brain dopamine is associated with eating behaviors in humans. Volkow, N.D., Wang, G.J., Maynard, L., Jayne, M., Fowler, J.S., Zhu, W., Logan, J., Gatley, S.J., Ding, Y.S., Wong, C., Pappas, N. Int. J. Eat. Disord (2003) [Pubmed]
  4. The addicted human brain: insights from imaging studies. Volkow, N.D., Fowler, J.S., Wang, G.J. J. Clin. Invest. (2003) [Pubmed]
  5. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Volkow, N.D., Wang, G.J., Fowler, J.S., Logan, J., Franceschi, D., Maynard, L., Ding, Y.S., Gatley, S.J., Gifford, A., Zhu, W., Swanson, J.M. Synapse (2002) [Pubmed]
  6. Changes in brain functional homogeneity in subjects with Alzheimer's disease. Volkow, N.D., Zhu, W., Felder, C.A., Mueller, K., Welsh, T.F., Wang, G.J., de Leon, M.J. Psychiatry. Res (2002) [Pubmed]
  7. "Nonhedonic" food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Volkow, N.D., Wang, G.J., Fowler, J.S., Logan, J., Jayne, M., Franceschi, D., Wong, C., Gatley, S.J., Gifford, A.N., Ding, Y.S., Pappas, N. Synapse (2002) [Pubmed]
  8. Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study. Volkow, N.D., Wang, G.J., Fowler, J.S., Thanos, P.P., Logan, J., Gatley, S.J., Gifford, A., Ding, Y.S., Wong, C., Pappas, N., Thanos, P. Synapse (2002) [Pubmed]
  9. Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Volkow, N.D., Fowler, J.S., Wang, G.J. Behav. Pharmacol (2002) [Pubmed]
  10. Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies. Volkow, N.D., Fowler, J.S., Wang, G.J., Ding, Y.S., Gatley, S.J. Eur. Neuropsychopharmacol (2002) [Pubmed]
  11. Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary study. Volkow, N.D., Wang, G.J., Maynard, L., Fowler, J.S., Jayne, B., Telang, F., Logan, J., Ding, Y.S., Gatley, S.J., Hitzemann, R., Wong, C., Pappas, N. Psychiatry. Res (2002) [Pubmed]
  12. Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Volkow, N.D., Fowler, J.S., Wang, G.J., Goldstein, R.Z. Neurobiol. Learn. Mem (2002) [Pubmed]
  13. Mechanism of action of methylphenidate: insights from PET imaging studies. Volkow, N.D., Fowler, J.S., Wang, G., Ding, Y., Gatley, S.J. J. Atten. Disord (2002) [Pubmed]
  14. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Volkow, N.D., Chang, L., Wang, G.J., Fowler, J.S., Leonido-Yee, M., Franceschi, D., Sedler, M.J., Gatley, S.J., Hitzemann, R., Ding, Y.S., Logan, J., Wong, C., Miller, E.N. Am. J. Psychiatry (2001) [Pubmed]
  15. Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Volkow, N.D., Chang, L., Wang, G.J., Fowler, J.S., Franceschi, D., Sedler, M.J., Gatley, S.J., Hitzemann, R., Ding, Y.S., Wong, C., Logan, J. Am. J. Psychiatry (2001) [Pubmed]
  16. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. Volkow, N.D., Chang, L., Wang, G.J., Fowler, J.S., Franceschi, D., Sedler, M., Gatley, S.J., Miller, E., Hitzemann, R., Ding, Y.S., Logan, J. J. Neurosci. (2001) [Pubmed]
  17. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Volkow, N.D., Chang, L., Wang, G.J., Fowler, J.S., Ding, Y.S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., Gifford, A., Wong, C., Pappas, N. Am. J. Psychiatry (2001) [Pubmed]
  18. Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. Volkow, N.D., Logan, J., Fowler, J.S., Wang, G.J., Gur, R.C., Wong, C., Felder, C., Gatley, S.J., Ding, Y.S., Hitzemann, R., Pappas, N. Am. J. Psychiatry (2000) [Pubmed]
  19. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Volkow, N.D., Fowler, J.S. Cereb. Cortex (2000) [Pubmed]
  20. Cocaine abusers show a blunted response to alcohol intoxication in limbic brain regions. Volkow, N.D., Wang, G.J., Fowler, J.S., Franceschi, D., Thanos, P.K., Wong, C., Gatley, S.J., Ding, Y.S., Molina, P., Schlyer, D., Alexoff, D., Hitzemann, R., Pappas, N. Life Sci. (2000) [Pubmed]
  21. Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain. Volkow, N.D., Wang, G.J., Fischman, M.W., Foltin, R., Fowler, J.S., Franceschi, D., Franceschi, M., Logan, J., Gatley, S.J., Wong, C., Ding, Y.S., Hitzemann, R., Pappas, N. Life Sci. (2000) [Pubmed]
  22. Increased activity of the temporal insula in subjects with bradycardia. Volkow, N.D., Wang, G.J., Fowler, J.S., Logan, J., Gatley, J.S., Pappas, N.R., Wong, C.T., Felder, C. Life Sci. (2000) [Pubmed]
  23. Resting brain metabolic activity in a 4 tesla magnetic field. Volkow, N.D., Wang, G.J., Fowler, J.S., Rooney, W.D., Felder, C.A., Lee, J.H., Franceschi, D., Maynard, L., Schlyer, D.J., Pan, J.W., Gatley, S.J., Springer Jr, C.S. Magn. Reson. Med (2000) [Pubmed]
  24. Comparable changes in synaptic dopamine induced by methylphenidate and by cocaine in the baboon brain. Volkow, N.D., Fowler, J.S., Gatley, S.J., Dewey, S.L., Wang, G.J., Logan, J., Ding, Y.S., Franceschi, D., Gifford, A., Morgan, A., Pappas, N., King, P. Synapse (1999) [Pubmed]
  25. Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain. Volkow, N.D., Wang, G.J., Fowler, J.S., Fischman, M., Foltin, R., Abumrad, N.N., Gatley, S.J., Logan, J., Wong, C., Gifford, A., Ding, Y.S., Hitzemann, R., Pappas, N. Life Sci. (1999) [Pubmed]
  26. Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Volkow, N.D., Wang, G.J., Fowler, J.S., Logan, J., Gatley, S.J., Gifford, A., Hitzemann, R., Ding, Y.S., Pappas, N. Am. J. Psychiatry (1999) [Pubmed]
  27. Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. Volkow, N.D., Wang, G.J., Fowler, J.S., Logan, J., Gatley, S.J., Wong, C., Hitzemann, R., Pappas, N.R. J. Pharmacol. Exp. Ther. (1999) [Pubmed]
  28. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. Volkow, N.D., Fowler, J.S., Wang, G.J. J. Psychopharmacol. (Oxford) (1999) [Pubmed]
  29. Imaging the neurochemistry of nicotine actions: studies with positron emission tomography. Volkow, N.D., Fowler, J.S., Ding, Y.S., Wang, G.J., Gatley, S.J. Nicotine Tob. Res. (1999) [Pubmed]
  30. Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction. Volkow, N.D., Wang, G.J., Fowler, J.S., Hitzemann, R., Angrist, B., Gatley, S.J., Logan, J., Ding, Y.S., Pappas, N. Am. J. Psychiatry (1999) [Pubmed]
  31. Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: a PET study. Volkow, N.D., Wang, G.J., Fowler, J.S., Hitzemann, R., Gatley, S.J., Dewey, S.S., Pappas, N. Am. J. Psychiatry (1998) [Pubmed]
  32. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Volkow, N.D., Gur, R.C., Wang, G.J., Fowler, J.S., Moberg, P.J., Ding, Y.S., Hitzemann, R., Smith, G., Logan, J. Am. J. Psychiatry (1998) [Pubmed]
  33. Differences in regional brain metabolic responses between single and repeated doses of methylphenidate. Volkow, N.D., Wang, G.J., Fowler, J.S., Hitzemann, R., Gatley, J., Ding, Y.S., Wong, C., Pappas, N. Psychiatry. Res (1998) [Pubmed]
  34. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Volkow, N.D., Wang, G.J., Fowler, J.S., Gatley, S.J., Logan, J., Ding, Y.S., Hitzemann, R., Pappas, N. Am. J. Psychiatry (1998) [Pubmed]
  35. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Volkow, N.D., Wang, G.J., Fowler, J.S., Logan, J., Gatley, S.J., Hitzemann, R., Chen, A.D., Dewey, S.L., Pappas, N. Nature (1997) [Pubmed]
 
WikiGenes - Universities